// App-Quantinova.ai

2316 : GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma

Researchers

Presenter

  • Thu Le Trinh

Principal Investigators

  • Qunfeng Wu

  • Lung-Ji Chang

  • Mitchell Ho

  • Chen Liu

Medical Centers

  • Moffitt Cancer Center, Tampa, FL

  • University of Florida, Cainsvillle, FL

  • National Cancer Institute, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 30

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved